Product Information
DONEPEZIL HCL ODT 10 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2912 per EA under NDC 33342003007. Its NADAC has been published 664 times since Jan 15, 2014.
FDA first approved this application on Dec 14, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342003007
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201787FDA Approved
12/14/2012
TE Code
AB
On Market Since
12/14/2012
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL ODT 10 MG TABLET has been published 664 times since Jan 15, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2912 per EA |
|---|---|
| All-time high | $0.4754 (Feb 12, 2014) |
| All-time low | $0.1705 (Mar 18, 2015) |
| 52-week high | $0.3234 |
| 52-week low | $0.2822 |
| Median price | $0.2704 |
| Average price | $0.2636 |
| Largest weekly change | +85.5% (Mar 20, 2019) |
| Weeks tracked | 664 |
| Tracking since | Jan 15, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Donepezil Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL ODT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL ODT 10 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.2912 per EA (NDC 33342003007), effective Sep 30, 2026.
How has the price of DONEPEZIL HCL ODT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL ODT 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 664 weekly CMS publications since Jan 15, 2014.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL ODT 10 MG TABLET?
Since Jan 15, 2014, the NADAC for DONEPEZIL HCL ODT 10 MG TABLET has ranged from a low of $0.1705 (Mar 18, 2015) to a high of $0.4754 (Feb 12, 2014), with a median of $0.2704 per EA.
Are there cheaper alternatives to DONEPEZIL HCL ODT 10 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DONEPEZIL HCL 10 MG TABLET, is $0.0484 per EA — about 83% below DONEPEZIL HCL ODT 10 MG TABLET.
Who manufactures DONEPEZIL HCL ODT 10 MG TABLET?
DONEPEZIL HCL ODT 10 MG TABLET (NDC 33342003007) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.